A. Hofmann

3.6k total citations
74 papers, 1.9k citations indexed

About

A. Hofmann is a scholar working on Organic Chemistry, Ecology, Evolution, Behavior and Systematics and Molecular Biology. According to data from OpenAlex, A. Hofmann has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 26 papers in Ecology, Evolution, Behavior and Systematics and 15 papers in Molecular Biology. Recurrent topics in A. Hofmann's work include Chemical synthesis and alkaloids (27 papers), Plant and fungal interactions (24 papers) and Botanical Research and Chemistry (11 papers). A. Hofmann is often cited by papers focused on Chemical synthesis and alkaloids (27 papers), Plant and fungal interactions (24 papers) and Botanical Research and Chemistry (11 papers). A. Hofmann collaborates with scholars based in Japan, Switzerland and Luxembourg. A. Hofmann's co-authors include F. Troxler, A. Frey, A. Stoll, H. Kobel, H. Ott, A. Brack, Richard R. Heim, Tom Reynolds, Richard Evans Schultes and Th. Petrzilka and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

A. Hofmann

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hofmann Japan 23 987 637 423 406 272 74 1.9k
F. Troxler Japan 14 507 0.5× 297 0.5× 280 0.7× 77 0.2× 90 0.3× 38 902
Th. Petrzilka Germany 12 320 0.3× 238 0.4× 163 0.4× 70 0.2× 292 1.1× 19 702
Dennis J. McKenna United States 25 498 0.5× 1.5k 2.4× 533 1.3× 41 0.1× 587 2.2× 44 2.7k
B. Witkop United States 20 410 0.4× 87 0.1× 478 1.1× 59 0.1× 134 0.5× 41 1.1k
C. A. Salemink Netherlands 18 299 0.3× 59 0.1× 322 0.8× 65 0.2× 334 1.2× 101 1.1k
A.G. Paul United States 11 220 0.2× 134 0.2× 214 0.5× 55 0.1× 67 0.2× 27 607
Yehiel Gaoni Israel 29 972 1.0× 329 0.5× 565 1.3× 60 0.1× 2.9k 10.5× 74 4.2k
G. W. KIRBY United Kingdom 19 642 0.7× 56 0.1× 392 0.9× 50 0.1× 208 0.8× 71 1.3k
Giorgio Ortar Italy 31 1.5k 1.5× 80 0.1× 547 1.3× 35 0.1× 950 3.5× 81 2.8k
Martin E. Kuehne United States 35 2.3k 2.3× 157 0.2× 985 2.3× 19 0.0× 233 0.9× 106 3.3k

Countries citing papers authored by A. Hofmann

Since Specialization
Citations

This map shows the geographic impact of A. Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hofmann more than expected).

Fields of papers citing papers by A. Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hofmann. The network helps show where A. Hofmann may publish in the future.

Co-authorship network of co-authors of A. Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hofmann. A scholar is included among the top collaborators of A. Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hofmann. A. Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmann, A., et al.. (1997). In vitro and in vivo effects of SCA40 on guinea pig airways. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(2). 217–223. 7 indexed citations
2.
Hofmann, A., et al.. (1996). KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(3). 355–61. 10 indexed citations
3.
Hofmann, A., et al.. (1995). Salbutamol-induced airway hyperreactivity in guinea pigs is not due to a loss of its bronchodilator effect. European Journal of Pharmacology. 287(1). 85–88. 20 indexed citations
4.
Waser, Peter G., et al.. (1989). Effects of new 4-aminopyridine derivatives on neuromuscular transmission and on smooth muscle contractility.. PubMed. 39(7). 762–5. 3 indexed citations
5.
Flückiger, E., U. Briner, Barbara J. Clark, et al.. (1988). Pharmacodynamic profile of CQP 201-403, a novel 8α-amino-ergoline. Cellular and Molecular Life Sciences. 44(5). 431–436. 9 indexed citations
6.
Hofmann, A., et al.. (1975). Characterization of the Active Site of Acetylcholinesterases by Application of Sterically Modified Acetylcholine Homologues. Croatica Chemica Acta. 47(3). 309–319. 3 indexed citations
7.
Hofmann, A., et al.. (1975). Affinity-labelling of the muscarinic receptor of the guinea-pig ileum. Naunyn-Schmiedeberg s Archives of Pharmacology. 289(3). 237–249. 3 indexed citations
8.
Schlientz, W., R. Brunner, A. Rüegger, et al.. (1968). [Beta-ergokryptin, a new alkaloid of ergotoxin-group. 67. Report on ergot alkaloids].. PubMed. 43(8). 497–509. 11 indexed citations
9.
Hofmann, A. & Conrad Hans Eugster. (1966). Synthese von 2,5‐Dimethyl‐3‐hydroxy‐Δ2‐furenidon‐(4), einer Aromakomponente der Ananasfrucht. Helvetica Chimica Acta. 49(1). 53–56. 6 indexed citations
10.
Hofmann, A., Wolfgang von Philipsborn, & Conrad Hans Eugster. (1965). NMR.‐Untersuchungen an einfachen Furenidonsystemen. Synthese des unsubstituierten Δ2‐Furenidons‐(4) («β‐Hydroxyfuran»). Helvetica Chimica Acta. 48(6). 1322–1331. 27 indexed citations
11.
Schlientz, W., R. Brunner, P. A. Stadler, et al.. (1964). Isolierung und Synthese des Ergostins, eines neuen Mutterkorn‐Alkaloids. 62. Mitteilung über Mutterkornalkaloide. Helvetica Chimica Acta. 47(7). 1921–1933. 12 indexed citations
12.
Stadler, P. A., A. Frey, & A. Hofmann. (1963). Herstellung der optisch aktiven Methyl‐benzyloxy‐malonsäurehalbester und Bestimmung ihrer absoluten Konfiguration. 57. Mitteilung über Mutterkornalkaloide. Helvetica Chimica Acta. 46(6). 2300–2305. 23 indexed citations
13.
Hofmann, A., Richard R. Heim, A. Brack, et al.. (1959). Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helvetica Chimica Acta. 42(5). 1557–1572. 165 indexed citations
14.
Heim, Richard R., et al.. (1958). [Determinism of carpophore and slerote formation in culture of Psilocybe mexicana Heim, a hallucinogenic agaric of Mexico and demonstration of psilocybine and psicoline].. PubMed. 246(9). 1346–51. 5 indexed citations
15.
16.
Hofmann, A.. (1955). β‐Yohimbin aus den Wurzeln von Rauwolfia canescens L. 6. Mitteilung über Rauwolfia‐Alkaloide. Helvetica Chimica Acta. 38(2). 536–538. 6 indexed citations
17.
Stoll, A., A. Hofmann, & R. Brunner. (1955). Alkaloide aus den Blättern von Rauwolfia canescens L. 4. Mitteilung über Rauwolfia‐Alkaloide. Helvetica Chimica Acta. 38(1). 270–283. 16 indexed citations
18.
Stoll, A. & A. Hofmann. (1955). Amide der stereoisomeren Lysergsäuren und Dihydro‐lysergsäuren. 38. Mitteilung über Mutterkornalkaloide. Helvetica Chimica Acta. 38(2). 421–433. 13 indexed citations
19.
Hofmann, A.. (1954). Rauhimbin und Isorauhimbin, zwei neue Alkaloide aus Rauwolfia serpentina Benth. 2. Mitteilung über Rauwolfia‐Alkaloide. Helvetica Chimica Acta. 37(1). 314–320. 21 indexed citations
20.
Stoll, A., A. Hofmann, & Th. Petrzilka. (1951). Die Konstitution der Mutterkornalkaloide. Struktur des Peptidteils. III. 24. Mitteilung über Mutterkornalkaloide. Helvetica Chimica Acta. 34(5). 1544–1576. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026